Reni Benjamin
Stock Analyst at Citizens JMP
(0.06)
# 4,784
Out of 5,078 analysts
796
Total ratings
33.5%
Success rate
-9%
Average return
Main Sectors:
Stocks Rated by Reni Benjamin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CMPX Compass Therapeutics | Reiterated: Buy | $10 → $4 | $0.761 | +425.62% | 2 | Sep 23, 2026 | |
| IOVA Iovance Biotherapeutics | Reiterated: Buy | $5 → $8 | $14.09 | -43.22% | 50 | Aug 7, 2026 | |
| ONC BeOne Medicines AG | Reiterated: Buy | $396 → $405 | $377.63 | +7.25% | 11 | Aug 6, 2026 | |
| STRO Sutro Biopharma | Reiterated: Buy | $35 → $41 | $9.33 | +339.44% | 47 | Apr 23, 2026 | |
| WHWK Whitehawk Therapeutics | Initiated Coverage: Buy | $8 | $3.21 | +149.22% | 1 | Apr 16, 2026 | |
| ALLO Allogene Therapeutics | Reiterated: Buy | $5 → $8 | $1.25 | +540.00% | 36 | Apr 14, 2026 | |
| BCYC Bicycle Therapeutics | Reiterated: Buy | $12 → $8 | $3.55 | +125.35% | 37 | Mar 18, 2026 | |
| IMMP Immutep | Downgraded: Hold | n/a | $3.20 | - | 2 | Mar 13, 2026 | |
| PRLD Prelude Therapeutics | Reiterated: Buy | $3 → $6 | $3.63 | +65.29% | 15 | Mar 11, 2026 | |
| IMMX Immix Biopharma | Initiated Coverage: Buy | $23 | $8.15 | +182.21% | 1 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $9.39 | +262.09% | 1 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $31 | $17.07 | +81.61% | 1 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.9801 | - | 12 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $28.22 | +13.39% | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $8 | $2.33 | +243.35% | 16 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.99 | n/a | 28 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $9.61 | n/a | 41 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $115.71 | n/a | 105 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $15.47 | n/a | 8 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.84 | n/a | 7 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $93.38 | n/a | 6 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $18.66 | n/a | 27 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.94 | n/a | 10 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0008 | n/a | 12 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.98 | n/a | 12 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.04 | n/a | 20 | May 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $6 | $0.03 | n/a | 19 | May 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.25 | n/a | 24 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $110 | $55.95 | n/a | 1 | Apr 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $5 | $1.00 | n/a | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 → $57 | $34.49 | n/a | 14 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $96 → $94 | $6.68 | n/a | 12 | Feb 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $0.5669 | n/a | 4 | Dec 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $5 | $2.28 | n/a | 25 | Nov 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $1.74 | n/a | 9 | Nov 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $10 | $10.68 | n/a | 17 | Oct 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $13 | $2.82 | n/a | 16 | Aug 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $54.17 | n/a | 25 | Aug 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.1485 | n/a | 8 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.11 | n/a | 21 | Aug 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.22 | n/a | 14 | Aug 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.54 | n/a | 10 | Dec 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.0169 | n/a | 7 | Jun 4, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $0.0001 | n/a | 1 | May 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.24 | n/a | 7 | May 21, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 5 | May 15, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $3 | $1.78 | n/a | 5 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $5 | $0.8524 | n/a | 6 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $12 | $5.93 | n/a | 7 | Mar 19, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.99 | n/a | 4 | Feb 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $6.33 | n/a | 6 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $0.000001 | n/a | 6 | Dec 11, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.33 | n/a | 3 | Oct 13, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $39.23 | n/a | 1 | May 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $39 | $17.73 | n/a | 1 | Jul 24, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.12 | n/a | 2 | Oct 12, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.62 | n/a | 2 | May 10, 2010 |
Compass Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $10 → $4
Current: $0.761
Upside: +425.62%
Iovance Biotherapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $5 → $8
Current: $14.09
Upside: -43.22%
BeOne Medicines AG
Aug 6, 2026
Reiterated: Buy
Price Target: $396 → $405
Current: $377.63
Upside: +7.25%
Sutro Biopharma
Apr 23, 2026
Reiterated: Buy
Price Target: $35 → $41
Current: $9.33
Upside: +339.44%
Whitehawk Therapeutics
Apr 16, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $3.21
Upside: +149.22%
Allogene Therapeutics
Apr 14, 2026
Reiterated: Buy
Price Target: $5 → $8
Current: $1.25
Upside: +540.00%
Bicycle Therapeutics
Mar 18, 2026
Reiterated: Buy
Price Target: $12 → $8
Current: $3.55
Upside: +125.35%
Immutep
Mar 13, 2026
Downgraded: Hold
Price Target: n/a
Current: $3.20
Upside: -
Prelude Therapeutics
Mar 11, 2026
Reiterated: Buy
Price Target: $3 → $6
Current: $3.63
Upside: +65.29%
Immix Biopharma
Mar 9, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $8.15
Upside: +182.21%
Mar 9, 2026
Initiated Coverage: Buy
Price Target: $34
Current: $9.39
Upside: +262.09%
Jan 29, 2026
Initiated Coverage: Buy
Price Target: $31
Current: $17.07
Upside: +81.61%
Dec 19, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.9801
Upside: -
Dec 3, 2025
Initiated Coverage: Buy
Price Target: $32
Current: $28.22
Upside: +13.39%
Oct 30, 2025
Reiterated: Buy
Price Target: $5 → $8
Current: $2.33
Upside: +243.35%
Oct 8, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.99
Upside: n/a
Sep 30, 2025
Reiterated: Buy
Price Target: $24
Current: $9.61
Upside: n/a
Sep 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $115.71
Upside: n/a
Sep 8, 2025
Reiterated: Buy
Price Target: $40
Current: $15.47
Upside: n/a
Aug 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $5.84
Upside: n/a
May 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $93.38
Upside: n/a
Apr 21, 2025
Reiterated: Buy
Price Target: $2
Current: $18.66
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $1.94
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $0.0008
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $4.98
Upside: n/a
May 10, 2019
Downgraded: Hold
Price Target: n/a
Current: $10.04
Upside: n/a
May 7, 2019
Reiterated: Buy
Price Target: $16 → $6
Current: $0.03
Upside: n/a
May 2, 2019
Reiterated: Hold
Price Target: n/a
Current: $2.25
Upside: n/a
Apr 9, 2019
Initiated Coverage: Buy
Price Target: $110
Current: $55.95
Upside: n/a
Mar 18, 2019
Reiterated: Buy
Price Target: $6 → $5
Current: $1.00
Upside: n/a
Mar 1, 2019
Reiterated: Buy
Price Target: $73 → $57
Current: $34.49
Upside: n/a
Feb 5, 2019
Upgraded: Buy
Price Target: $96 → $94
Current: $6.68
Upside: n/a
Dec 13, 2018
Reiterated: Buy
Price Target: $21
Current: $0.5669
Upside: n/a
Nov 15, 2018
Upgraded: Buy
Price Target: $5
Current: $2.28
Upside: n/a
Nov 14, 2018
Upgraded: Buy
Price Target: n/a
Current: $1.74
Upside: n/a
Oct 12, 2018
Reiterated: Buy
Price Target: $11 → $10
Current: $10.68
Upside: n/a
Aug 28, 2018
Reiterated: Buy
Price Target: $13 → $13
Current: $2.82
Upside: n/a
Aug 14, 2018
Reiterated: Buy
Price Target: $22
Current: $54.17
Upside: n/a
Aug 10, 2018
Reiterated: Hold
Price Target: n/a
Current: $0.1485
Upside: n/a
Aug 7, 2018
Reiterated: Hold
Price Target: n/a
Current: $2.11
Upside: n/a
Aug 7, 2018
Reiterated: Hold
Price Target: n/a
Current: $8.22
Upside: n/a
Dec 18, 2017
Rated: Hold
Price Target: n/a
Current: $11.54
Upside: n/a
Jun 4, 2015
Reiterated: Buy
Price Target: $6
Current: $0.0169
Upside: n/a
May 26, 2015
Initiated Coverage: Buy
Price Target: $13
Current: $0.0001
Upside: n/a
May 21, 2015
Reiterated: Buy
Price Target: $8
Current: $1.24
Upside: n/a
May 15, 2015
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 31, 2015
Reiterated: Buy
Price Target: $7 → $3
Current: $1.78
Upside: n/a
Mar 31, 2015
Reiterated: Buy
Price Target: $9 → $5
Current: $0.8524
Upside: n/a
Mar 19, 2015
Reiterated: Buy
Price Target: $8 → $12
Current: $5.93
Upside: n/a
Feb 18, 2015
Reiterated: Buy
Price Target: $4
Current: $0.99
Upside: n/a
Jan 9, 2015
Reiterated: Buy
Price Target: $6
Current: $6.33
Upside: n/a
Dec 11, 2014
Reiterated: Buy
Price Target: $40
Current: $0.000001
Upside: n/a
Oct 13, 2014
Reiterated: Hold
Price Target: n/a
Current: $1.33
Upside: n/a
May 5, 2014
Initiated Coverage: Buy
Price Target: $17
Current: $39.23
Upside: n/a
Jul 24, 2013
Downgraded: Hold
Price Target: $39
Current: $17.73
Upside: n/a
Oct 12, 2010
Reiterated: Buy
Price Target: $9
Current: $1.12
Upside: n/a
May 10, 2010
Reiterated: Buy
Price Target: n/a
Current: $8.62
Upside: n/a